Newsroom

Sorted by: Latest

-

SEPRO Scientific™ Announces Strategic Technology Partnership with Oase, Expanding Surface Water Solutions

CARMEL, Ind. & AURORA, Ohio--(BUSINESS WIRE)--SEPRO Scientific™ and Oase today announced the signing of a Memorandum of Understanding establishing a strategic partnership to expand access to innovative surface water technology solutions for customers across the United States and Canada. The partnership brings together Oase’s technology and product knowledge with SEPRO Scientific’s field and technical expertise, proven capabilities, and long-standing commitment to water stewardship. Together, th...
-

The Cordis SELUTION SLR SUSTANE™ PTA Drug Eluting Balloon achieves highest reported Primary Patency in US IDE Trial

MIAMI LAKES, Fla.--(BUSINESS WIRE)--Cordis, a global leader in interventional cardiovascular and endovascular technologies, today announced that the SELUTION SLR SUSTANE™ PTA Drug-Eluting Balloon (SUSTANE DEB) achieved the highest reported 12-month primary patency in the SELUTION4SFA US pivotal trial at 90.3%. The results were presented during a Late-Breaking Clinical Trial session at VIVA 2026 by Jay Mathews, MD, MS, Director, Cardiac Catheterization Laboratory, PERT & Structural Heart at...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 05.10.2026 FJUL.LN IE000YJBT6I5  150,002.00 USD   4,435,741.11   29.571  ...
-

NATIXIS UK Regulatory Announcement: Form 8.3 Intertek group plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...
-

Bain & Company to Sponsor Executive Summit at Seismic Shift 2026

SAN DIEGO--(BUSINESS WIRE)--Bain and Seismic are working together to help financial services firms, global enterprises improve sales execution and transform GTM workflows....
-

WSFS Announces Executive Leadership Appointments

WILMINGTON, Del.--(BUSINESS WIRE)--WSFS Financial Corporation (Nasdaq: WSFS), today announced the appointment of Charles “Chuck” Mosher as Executive Vice President, Chief Audit Executive, and the promotion of Lisa Washington, to Executive Vice President, Chief Legal Officer and Corporate Secretary, effective today. Mosher and Washington are both experienced members of the WSFS senior leadership team and will continue to lead two critical areas of the company’s governance and risk management fra...
-

As Factories Go Driverless, Trio Mobil Supports the Safe Coexistence of AGVs and Forklifts

INGOLSTADT, Germany--(BUSINESS WIRE)--The factory floor is undergoing its most significant transformation in decades. Automated guided vehicles are now a structural feature of modern automotive manufacturing, with the global AGV market on track to nearly double to over $11 billion by 2030, according to Grand View Research. At Audi's Ingolstadt operations, AGVs already share production corridors with human-operated forklifts every hour of every shift. That convergence is exactly where AGVs and fo...
-

ViiV Healthcare’s long-acting HIV treatment Cabenuva (cabotegravir + rilpivirine) meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced the phase IIIb CROWN study met its primary endpoint, demonstrating that at six months, long-acting Cabenuva (cabotegravir + rilpivirine [CAB + RPV LA]) achieved superior rates of viral suppression compared with standard-of-care oral antiretroviral therapy (ART) in adults and adolescents living with HIV-1 who had detectable virus when they entered the...
-

Enko Identifies Novel Fungicide and Insecticide Modes of Action Using ENKOMPASS™

MYSTIC, Conn.--(BUSINESS WIRE)--Enko Chem, Inc. today announced that it has utilized its ENKOMPASS™ platform to rapidly and cost-effectively identify novel modes of action (MOAs) for fungicides and insecticides. The newly identified MOAs draw on previously untapped biology and extend this use of ENKOMPASS across all three crop protection categories: herbicides, fungicides and insecticides. The new MOAs offer differentiated approaches to some of the most challenging pests and diseases facing agr...
-

Summit Wealth Group Acquires Commonwealth Advisor, Expands Tennessee Presence

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Summit Wealth Group (Summit), a national independent RIA, today announced the acquisition of financial advisor Scott Hardy and his practice, representing approximately $189 million in client assets. Hardy, who is transitioning from Commonwealth Financial Network, will serve clients from Summit’s existing Brentwood, Tennessee office. Hardy's addition marks another milestone in Summit's growth following its 2025 transition from Commonwealth. Hardy brings...